Lamhamedi-Cherradi, Salah-EddineSantoro, MarcoRamammoorthy, VandhanaMenegaz, Brian A.Bartholomeusz, GeoffreyIles, Lakesla R.Amin, Hesham M.Livingston, J. AndrewMikos, Antonios G.Ludwig, Joseph A.2015-03-192015-03-192014Lamhamedi-Cherradi, Salah-Eddine, Santoro, Marco, Ramammoorthy, Vandhana, et al.. "3D tissue-engineered model of Ewing's sarcoma." <i>Advanced Drug Delivery Reviews,</i> 79-80, (2014) Elsevier: 155-171. http://dx.doi.org/10.1016/j.addr.2014.07.012.https://hdl.handle.net/1911/79384Despite longstanding reliance upon monolayer culture for studying cancer cells, and numerous advantages from both a practical and experimental standpoint, a growing body of evidence suggests that more complex three-dimensional (3D) models are necessary to properly mimic many of the critical hallmarks associated with the oncogenesis, maintenance and spread of Ewing's sarcoma (ES), the second most common pediatric bone tumor. And as clinicians increasingly turn to biologically-targeted therapies that exert their effects not only on the tumor cells themselves, but also on the surrounding extracellular matrix, it is especially important that preclinical models evolve in parallel to reliably measure antineoplastic effects and possible mechanisms of de novo and acquired drug resistance. Herein, we highlight a number of innovative methods used to fabricate biomimetic ES tumors, encompassing both the surrounding cellular milieu and the extracellular matrix (ECM), and suggest potential applications to advance our understanding of ES biology, preclinical drug testing, and personalized medicine.engThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Journal articleEwing's sarcomaMCTS3Dtissue-engineeringscaffoldsECMtumor modelpreclinical testinghttp://dx.doi.org/10.1016/j.addr.2014.07.012